Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
Preeclampsia (PE) is a rising, potentially lethal complication of pregnancy. PE is driven primarily by the overexpression of placental soluble fms-like tyrosine kinase 1 (sFLT1), a validated diagnostic and prognostic marker of the disease when normalized to placental growth factor (PlGF) levels. Inj...
Saved in:
Main Authors: | Sarah M. Davis (Author), Vignesh N. Hariharan (Author), Agnes Lo (Author), Anton A. Turanov (Author), Dimas Echeverria (Author), Jacquelyn Sousa (Author), Nicholas McHugh (Author), Annabelle Biscans (Author), Julia F. Alterman (Author), S. Ananth Karumanchi (Author), Melissa J. Moore (Author), Anastasia Khvorova (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019) -
Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in mouse and pig photoreceptors
by: Shun-Yun Cheng, et al.
Published: (2024) -
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
by: Socheata Ly, et al.
Published: (2020) -
2'-O-Methyl at 20-mer Guide Strand 3' Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
by: Sarah M. Davis, et al.
Published: (2020) -
Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017)